GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $615,668 (100.0% shares, 0.0% debt)

Holdings (33)

GW PHARMACEUTICALS PLC 7.3%
Value ($000) $45,010 Shares 390,000 Est. Cost $93.52 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 6.9%
Value ($000) $42,569 Shares 917,427 Est. Cost $18.64 Unrealized +113.0%
SAGE THERAPEUTICS INC 6.4%
Value ($000) $39,312 Shares 454,417 Est. Cost $46.88 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 6.3%
Value ($000) $38,518 Shares 720,502 Est. Cost $30.25 Unrealized +64.1%
RCKT ROCKET PHARMACEUTICALS INC 6.2%
Value ($000) $38,388 Shares 700,000 Est. Cost $36.45 Unrealized 0.0%
ZYMEWORKS INC 6.1%
Value ($000) $37,795 Shares 799,722 Est. Cost $8101.10 Unrealized
INTERSECT ENT INC 4.8%
Value ($000) $29,836 Shares 1,302,871 Est. Cost $19.12 Unrealized
CONSTELLATION PHARMCETICLS I 4.8%
Value ($000) $29,514 Shares 1,024,800 Est. Cost $35.95 Unrealized
MGNX MACROGENICS INC 4.6%
Value ($000) $28,330 Shares 1,239,287 Est. Cost $17.37 Unrealized +32.5%
VCEL VERICEL CORP 4.5%
Value ($000) $27,792 Shares 900,000 Est. Cost $13.53 Unrealized +75.9%
ARENA PHARMACEUTICALS INC 4.3%
Value ($000) $26,516 Shares 345,120 Est. Cost $56.72 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 4.2%
Value ($000) $25,790 Shares 595,473 Est. Cost $61.75 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 3.7%
Value ($000) $22,769 Shares 150,000 Est. Cost $85.83 Unrealized +52.9%
OCUL OCULAR THERAPEUTIX INC 2.9%
Value ($000) $17,723 Shares 856,162 Est. Cost $14.85 Unrealized 0.0%
KADMON HLDGS INC 2.8%
Value ($000) $16,948 Shares 4,083,909 Est. Cost $4.21 Unrealized
PODD INSULET CORP 2.5%
Value ($000) $15,338 Shares 60,000 Est. Cost $248.10 Unrealized 0.0%
TBPH THERAVANCE BIOPHARMA INC 2.4%
Value ($000) $14,653 Shares 824,580 Est. Cost $17.95 Unrealized 0.0%
ARVN ARVINAS INC 2.3%
Value ($000) $13,941 Shares 164,150 Est. Cost $34.48 Unrealized 0.0%
PBYI PUMA BIOTECHNOLOGY INC 2.2%
Value ($000) $13,338 Shares 1,300,000 Est. Cost $10.19 Unrealized -0.6%
MERSANA THERAPEUTICS INC 2.1%
Value ($000) $12,971 Shares 487,452 Est. Cost $26.61 Unrealized
PRTA PROTHENA CORP PLC 1.9%
Value ($000) $11,742 Shares 977,647 Est. Cost $10.02 Unrealized +18.0%
EXEL EXELIXIS INC 1.5%
Value ($000) $9,533 Shares 475,000 Est. Cost $20.93 Unrealized 0.0%
CALITHERA BIOSCIENCES INC 1.5%
Value ($000) $9,059 Shares 1,845,000 Est. Cost $4.87 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 1.4%
Value ($000) $8,440 Shares 421,383 Est. Cost $19.53 Unrealized 0.0%
FORMA THERAPEUTICS HLDGS INC 1.3%
Value ($000) $8,250 Shares 236,400 Est. Cost $34.90 Unrealized
GERN GERON CORP 1.3%
Value ($000) $8,038 Shares 5,055,189 Est. Cost $1.49 Unrealized +21.9%
FIBROGEN INC 1.0%
Value ($000) $6,176 Shares 166,500 Est. Cost Unrealized
LUNG PULMONX CORP 0.7%
Value ($000) $4,441 Shares 64,345 Est. Cost $48.97 Unrealized 0.0%
IONS IONIS PHARMACEUTICALS INC 0.7%
Value ($000) $4,241 Shares 75,000 Est. Cost $49.83 Unrealized 0.0%
SPRY SILVERBACK THERAPEUTICS INC 0.5%
Value ($000) $3,244 Shares 70,000 Est. Cost $33.40 Unrealized 0.0%
CALITHERA BIOSCIENCES INC 0.4%
Value ($000) $2,455 Shares 500,000 Est. Cost $4.87 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.4%
Value ($000) $2,420 Shares 175,000 Est. Cost $14.49 Unrealized +0.5%
MILLENDO THERAPEUTICS INC 0.1%
Value ($000) $578 Shares 270,000 Est. Cost $7.64 Unrealized